Halper Sadeh investigates Cross Country Healthcare sale to Knox Lane at $13.25 a share

The investor rights law firm said it is reviewing whether Cross Country’s board secured the best available price and provided shareholders enough information to assess the cash deal.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.